Adequate 0 8 0 8 O
hepatic 9 16 9 16 B-clinical_variable
function 17 25 17 25 I-clinical_variable
( 26 27 26 27 O
> 27 28 27 28 O
= 28 29 28 29 O
1.5 30 33 30 33 B-lower_bound
x 34 35 34 35 I-lower_bound
upper 36 41 36 41 I-lower_bound
limit 42 47 42 47 I-lower_bound
of 48 50 48 50 I-lower_bound
normal 51 57 51 57 I-lower_bound
[ 58 59 58 59 I-lower_bound
ULN 59 62 59 62 I-lower_bound
] 62 63 62 63 I-lower_bound

Any 0 3 64 67 O
unstable 4 12 68 76 O
, 12 13 76 77 O
serious 14 21 78 85 O
co 22 24 86 88 O
- 24 25 88 89 O
existing 25 33 89 97 O
medical 34 41 98 105 O
conditions 42 52 106 116 O
including 53 62 117 126 O
but 63 66 127 130 O
not 67 70 131 134 O
limited 71 78 135 142 O
to 79 81 143 145 O
myocardial 82 92 146 156 B-chronic_disease
infarction 93 103 157 167 I-chronic_disease
, 103 104 167 168 O
coronary 105 113 169 177 B-treatment
bypass 114 120 178 184 I-treatment
surgery 121 128 185 192 I-treatment
, 128 129 192 193 O
unstable 130 138 194 202 B-chronic_disease
angina 139 145 203 209 I-chronic_disease
, 145 146 209 210 O
cardiac 147 154 211 218 B-chronic_disease
arrhythmias 155 166 219 230 I-chronic_disease
, 166 167 230 231 O
clinically 168 178 232 242 O
evident 179 186 243 250 O
congestive 187 197 251 261 B-chronic_disease
heart 198 203 262 267 I-chronic_disease
failure 204 211 268 275 I-chronic_disease
, 211 212 275 276 O
or 213 215 277 279 O
cerebrovascular 216 231 280 295 B-chronic_disease
accident 232 240 296 304 I-chronic_disease
within 241 247 305 311 O
twelve 248 254 312 318 B-upper_bound
( 255 256 319 320 I-upper_bound
12 256 258 320 322 I-upper_bound
) 258 259 322 323 I-upper_bound
months 260 266 324 330 I-upper_bound
prior 267 272 331 336 I-upper_bound
to 273 275 337 339 O
screening 276 285 340 349 O

Current 0 7 350 357 O
use 8 11 358 361 O
of 12 14 362 364 O
exogenous 15 24 365 374 B-treatment
testosterone 25 37 375 387 I-treatment

Eastern 0 7 388 395 B-clinical_variable
Cooperative 8 19 396 407 I-clinical_variable
Oncology 20 28 408 416 I-clinical_variable
Group 29 34 417 422 I-clinical_variable
( 35 36 423 424 I-clinical_variable
ECOG 36 40 424 428 I-clinical_variable
) 40 41 428 429 I-clinical_variable
performance 42 53 430 441 I-clinical_variable
status 54 60 442 448 I-clinical_variable
= 61 62 449 450 O
< 62 63 450 451 O
2 64 65 452 453 B-upper_bound

History 0 7 454 461 O
of 8 10 462 464 O
loss 11 15 465 469 O
of 16 18 470 472 O
consciousness 19 32 473 486 O
or 33 35 487 489 O
transient 36 45 490 499 B-chronic_disease
ischemic 46 54 500 508 I-chronic_disease
attack 55 61 509 515 I-chronic_disease
within 62 68 516 522 O
twelve 69 75 523 529 B-upper_bound
( 76 77 530 531 I-upper_bound
12 77 79 531 533 I-upper_bound
) 79 80 533 534 I-upper_bound
months 81 87 535 541 I-upper_bound
of 88 90 542 544 O
enrollment 91 101 545 555 O

History 0 7 556 563 O
of 8 10 564 566 O
seizure 11 18 567 574 B-chronic_disease
or 19 21 575 577 O
any 22 25 578 581 O
condition 26 35 582 591 O
that 36 40 592 596 O
may 41 44 597 600 O
predispose 45 55 601 611 O
to 56 58 612 614 O
seizure 59 66 615 622 O
( 67 68 623 624 O
e.g. 68 72 624 628 O
, 72 73 628 629 O
prior 74 79 630 635 O
cortical 80 88 636 644 B-chronic_disease
stroke 89 95 645 651 I-chronic_disease
or 96 98 652 654 O
significant 99 110 655 666 O
brain 111 116 667 672 B-chronic_disease
trauma 117 123 673 679 I-chronic_disease
) 123 124 679 680 O

History 0 7 681 688 O
of 8 10 689 691 O
unprovoked 11 21 692 702 O
deep 22 26 703 707 B-chronic_disease
vein 27 31 708 712 I-chronic_disease
thrombosis 32 42 713 723 I-chronic_disease
/ 42 43 723 724 I-chronic_disease
pulmonary 43 52 724 733 I-chronic_disease
embolism 53 61 734 742 I-chronic_disease
( 62 63 743 744 I-chronic_disease
DVT 63 66 744 747 I-chronic_disease
/ 66 67 747 748 I-chronic_disease
PE 67 69 748 750 I-chronic_disease
) 69 70 750 751 I-chronic_disease
in 71 73 752 754 O
past 74 78 755 759 O
twelve 79 85 760 766 O
( 86 87 767 768 O
12 87 89 768 770 O
) 89 90 770 771 O
months 91 97 772 778 O

Men 0 3 779 782 B-gender
must 4 8 783 787 O
use 9 12 788 791 B-contraception_consent
adequate 13 21 792 800 I-contraception_consent
methods 22 29 801 808 I-contraception_consent
of 30 32 809 811 I-contraception_consent
contraception 33 46 812 825 I-contraception_consent
during 47 53 826 832 O
and 54 57 833 836 O
at 58 60 837 839 O
least 61 66 840 845 O
3 67 68 846 847 B-lower_bound
months 69 75 848 854 I-lower_bound
after 76 81 855 860 O
treatment 82 91 861 870 O
if 92 94 871 873 O
engaging 95 103 874 882 O
in 104 106 883 885 O
sexual 107 113 886 892 O
activity 114 122 893 901 O
with 123 127 902 906 O
a 128 129 907 908 O
female 130 136 909 915 B-gender
of 137 139 916 918 O
child 140 145 919 924 O
bearing 146 153 925 932 O
age 154 157 933 936 B-age

Metastatic 0 10 937 947 B-cancer
RCC 11 14 948 951 I-cancer

No 0 2 952 954 O
evidence 3 11 955 963 O
of 12 14 964 966 O
metastatic 15 25 967 977 B-cancer
disease 26 33 978 985 I-cancer
on 34 36 986 988 O
baseline 37 45 989 997 O
imaging 46 53 998 1005 O
( 54 55 1006 1007 O
chest 55 60 1007 1012 O
x 61 62 1013 1014 O
- 62 63 1014 1015 O
ray 63 66 1015 1018 O
[ 67 68 1019 1020 O
CXR 68 71 1020 1023 O
] 71 72 1023 1024 O
or 73 75 1025 1027 O
chest 76 81 1028 1033 O
CT 82 84 1034 1036 O
, 84 85 1036 1037 O
abdominal 86 95 1038 1047 O
CT 96 98 1048 1050 O
or 99 101 1051 1053 O
MRI 102 105 1054 1057 O
) 105 106 1057 1058 O

Pregnant 0 8 1059 1067 B-pregnancy
women 9 14 1068 1073 B-gender
or 15 17 1074 1076 O
women 18 23 1077 1082 O
who 24 27 1083 1086 O
are 28 31 1087 1090 O
of 32 34 1091 1093 O
child 35 40 1094 1099 O
bearing 41 48 1100 1107 O
age 49 52 1108 1111 B-age
who 53 56 1112 1115 O
are 57 60 1116 1119 O
not 61 64 1120 1123 B-contraception_consent
willing 65 72 1124 1131 I-contraception_consent
to 73 75 1132 1134 I-contraception_consent
use 76 79 1135 1138 I-contraception_consent
two 80 83 1139 1142 I-contraception_consent
( 84 85 1143 1144 I-contraception_consent
2 85 86 1144 1145 I-contraception_consent
) 86 87 1145 1146 I-contraception_consent
forms 88 93 1147 1152 I-contraception_consent
of 94 96 1153 1155 I-contraception_consent
contraception 97 110 1156 1169 I-contraception_consent
during 111 117 1170 1176 O
treatment 118 127 1177 1186 B-treatment
with 128 132 1187 1191 I-treatment
enzalutamide 133 145 1192 1204 I-treatment
and 146 149 1205 1208 O
for 150 153 1209 1212 O
six 154 157 1213 1216 B-upper_bound
( 158 159 1217 1218 I-upper_bound
6 159 160 1218 1219 I-upper_bound
) 160 161 1219 1220 I-upper_bound
months 162 168 1221 1227 I-upper_bound
after 169 174 1228 1233 O
treatment 175 184 1234 1243 O

Prior 0 5 1244 1249 O
use 6 9 1250 1253 O
of 10 12 1254 1256 O
androgen 13 21 1257 1265 B-treatment
deprivation 22 33 1266 1277 I-treatment
including 34 43 1278 1287 O
enzalutamide 44 56 1288 1300 B-treatment

Retroperitoneal 0 15 1301 1316 B-chronic_disease
/ 15 16 1316 1317 I-chronic_disease
hilar 16 21 1317 1322 I-chronic_disease
adenopathy 22 32 1323 1333 I-chronic_disease
concerning 33 43 1334 1344 O
for 44 47 1345 1348 O
locally 48 55 1349 1356 O
advanced 56 64 1357 1365 O
disease 65 72 1366 1373 O

Tumor 0 5 1374 1379 B-cancer
with 6 10 1380 1384 O
androgen 11 19 1385 1393 B-clinical_variable
receptor 20 28 1394 1402 I-clinical_variable
( 29 30 1403 1404 I-clinical_variable
AR 30 32 1404 1406 I-clinical_variable
) 32 33 1406 1407 I-clinical_variable
expressed 34 43 1408 1417 O
> 44 45 1418 1419 O
= 45 46 1419 1420 O
4580 47 51 1421 1425 B-lower_bound
copies 52 58 1426 1432 I-lower_bound
/ 58 59 1432 1433 I-lower_bound
ug 59 61 1433 1435 I-lower_bound
ribonucleic 62 73 1436 1447 O
acid 74 78 1448 1452 O
( 79 80 1453 1454 O
RNA 80 83 1454 1457 O
) 83 84 1457 1458 O

patient 0 7 1459 1466 O
's 7 9 1466 1468 O
with 10 14 1469 1473 O
Gilbert 15 22 1474 1481 B-chronic_disease
's 22 24 1481 1483 I-chronic_disease
disease 25 32 1484 1491 I-chronic_disease
are 33 36 1492 1495 O
not 37 40 1496 1499 O
excluded 41 49 1500 1508 O

